A total of 3025 families with schoolchildren aged 6-8 years were offered pilot screening for familial hypercholesterolaemia by measurement of the concentrations of apolipoproteins A-1 and B in the children's capillary blood and by analysis of their family histories of early ischaemic heart disease. The concentrations of the apolipoproteins were determined by double rocket immunoelectrophoresis of an eluate of blood spotted on filter paper. Results were available from 2085 children. Because their B:A-1 ratio was above the 97.5 centile and their concentration of B was above the 99th centile, 54 children (2-6%) were selected to have their apolipoprotein concentrations reassessed. The 17 children (0.8%) whose values were persistently above the chosen cut off points, and all of their available first and second degree relatives, had fasting determinations of serum lipid concentrations carried out. Raised serum concentrations of low density lipoprotein cholesterol and an autosomal dominant pattern of hypercholesterolaemia were found in 12 children and 10 families, respectively, suggesting a higher incidence of familial hypercholesterolaemia than the reported 1:500. Further investigations among family members disclosed hypercholesterolaemia in 29 relatives. A family history of early ischaemic heart disease was elicited by questionnaire, and was positive in only five of the 12 schoolchildren with hypercholesterolaemia.
Abstract
A total of 3025 families with schoolchildren aged 6-8 years were offered pilot screening for familial hypercholesterolaemia by measurement of the concentrations of apolipoproteins A-1 and B in the children's capillary blood and by analysis of their family histories of early ischaemic heart disease. The concentrations of the apolipoproteins were determined by double rocket immunoelectrophoresis of an eluate of blood spotted on filter paper. Results were available from 2085 children. Because their B:A-1 ratio was above the 97.5 centile and their concentration of B was above the 99th centile, 54 children (2-6%) were selected to have their apolipoprotein concentrations reassessed. The 17 children (0.8%) whose values were persistently above the chosen cut off points, and all of their available first and second degree relatives, had fasting determinations of serum lipid concentrations carried out. Raised serum concentrations of low density lipoprotein cholesterol and an autosomal dominant pattern of hypercholesterolaemia were found in 12 children and 10 families, respectively, suggesting a higher incidence of familial hypercholesterolaemia than the reported 1:500. Further investigations among family members disclosed hypercholesterolaemia in 29 relatives. A family history of early ischaemic heart disease was elicited by questionnaire, and was positive in only five of the 12 schoolchildren with hypercholesterolaemia.
We conclude that analysis of apolipoproteins from capillary blood spotted on filter paper is suitable for screening for familial hypercholesterolaemia, and that this method is more efficient than screening based on family history.
Heterozygous familial hypercholesterolaemia has an overall incidence in various populations of about 1:500, making it one of the most common inborn errors of metabolism.' Affected adults have a significantly increased risk of early ischaemic vascular disease including fatal myocardial infarction. In people without known predisposition to hypercholesterolaemia, raised concentrations of total cholesterol and low density lipoprotein cholesterol, which are present from birth in familial hypercholesterolaemia,2 are strongly correlated with early (20 years old) atherosclerotic lesions in the aorta and coronary arteries. 3 The apparent onset of atherosclerosis in childhood makes the detection and proper management of children with hypercholesterolaemia (including familial hypercholesterolaemia) a matter of concern to many paediatricians.
This paper describes a pilot screening progranmme for familial hypercholesterolaemia among schoolchildren by measuring the concentrations of apolipoproteins A-I and B in capillary blood.
Patients and methods
In August 1987, 3025 families with children aged 6-8 years who were starting in the first grade of the Copenhagen school system were offered the chance to participate in a pilot screening programme for the detection of familial hypercholesterolaemia. The parents were asked to answer a questionnaire about the occurrence of coronary heart disease in their families. Upon completion of the questionnaire, the parents were requested to give their permission for blood samples to be taken from their child.
Capillary blood was obtained from the children without prior fasting between 8 The children listed in the table were all normal on physical examinations, except for one child who was obese (case 98). Laboratory investigations of the causes of secondary hyperlipidaemia were unrevealing. All but one of the families were interested in counselling and follow up for the children with hypercholesterolaemia. Information about risk factors for atherosclerotic vascular disease and about the principles behind a diet to lower blood cholesterol concentrations was offered by the physician in the paediatric lipid clinic. Particular emphasis was placed on a reduction of the intake of saturated fats from meat and dairy products, because both of these feature largely in the traditional Danish diet. The children were then seen at three to six month intervals and height, weight, and lipid profile were measured. After six to 12 months a three day dietary history was recorded by a dietitian, and the daily intakes of energy, saturated and polyunsaturated fats, and cholesterol were calculated. Further advice depended upon the reduction of total and low density lipoprotein cholesterol concentrations achieved and on the dietary history. Two years after diagnosis no child had required hyperlipidaemic drugs.
Analysis of the 2657 completed questionnaires disclosed a history of early ischaemic heart disease in 398 families (15-0%). Of the 491 families who did give permission for blood samples to be taken from their children, 27 gave a positive family history by questionnaire (5 5%). Only five of the 12 children identified as having hypercholesterolaemia by apolipoprotein analysis had a positive family history of early ischaemic heart disease on the questionnaire.
Discussion
According to official recommendations screening of children for hypercholesterolaemia should be directed at high risk groups-that is, those with a family history of cardiovascular disease or hyperlipidaemia.7 8 Several concerns have been raised about a low risk, population based approach, including the cost of techniques for measuring cholesterol and the ability of the tests to detect all children with raised low density lipoprotein cholesterol concentrations. Andersen et al have shown that it is feasible to screen newborns for hyperlipoproteinaemia by measuring very low density lipoprotein and low density lipoprotein cholesterol concentrations in cord blood, a method which is impractical for routine neonatal screening.9 More recently, newborn infants have been screened for familial hypercholesterolaemia by measurement of apolipoprotein B in capillary blood. '0 The methods used in the present study were developed for the same purpose-that is, to screen newborns for familial hypercholesterolaemia using blood from the filter paper currently used in Denmark to screen for phenylketonuria and congenital hypothyroidism. The method used for analysis of apolipoproteins is based on immunological quantification of these substances from small amounts of capillary blood easily obtained from infants, and it is suitable for screening a large number of children. 4 Familial hypercholesterolaemia is characterised by raised serum low density lipoprotein cholesterol concentration. Direct measurement of this lipoprotein is difficult, and an estimate based on the serum values of other lipid fractions requires larger amounts of blood than are normally obtainable from capillary samples. Several studies have suggested that the circulating concentration of apolipoprotein B, the apoprotein of low density lipoprotein, is a better predictor of premature coronary artery disease than is the total plasma cholesterol concentration.1' The absolute concentrations of apolipoproteins in blood absorbed in filter paper cannot be determined accurately because the precise volume of blood is not known.4 This difficulty is circumvented by the simultaneous measurement of apolipoprotein A-1 and the use of the B:A-1 ratio as the criterion for detection of familial hypercholesterolaemia. In capillary blood from 68 such patients aged 4-42 years we have previously found the B:A-l ratio to be consistently above 0-90. 4 We therefore took the ratio.of 0-83, or the 97-5 centile of our study group, as the threshold for recall so that we had a wide enough margin to avoid false negative results. Our data did not allow an estimate of the number of false negative results-that is we cannot find out how many children with B:A-1 ratios below 0 83 have hypercholesterolaemia. None the less, the unexpected high incidence of familial cases of hypercholesterolaemia ( '6 In contrast to screening of adults for hypercholesterolaemia, the usefulness of total serum cholesterol concentration as a screening test for raised low density lipoprotein cholesterol concentrations in children is limited by the higher concentrations of high density lipoprotein cholesterol in many children and adolescents than in adults. 7 Apolipoprotein B has test characteristics superior to those of total cholesterol concentration in detecting raised concentrations of low density lipoprotein cholesterol in serum. '8 Our findings confirm the feasibility of using measurement of capillary apolipoproteins as a screening test for hypercholesterolaemia in children.
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